1. Home
  2. SRPT vs IIPR Comparison

SRPT vs IIPR Comparison

Compare SRPT & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • IIPR
  • Stock Information
  • Founded
  • SRPT 1980
  • IIPR 2016
  • Country
  • SRPT United States
  • IIPR United States
  • Employees
  • SRPT N/A
  • IIPR N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • IIPR Real Estate
  • Sector
  • SRPT Health Care
  • IIPR Finance
  • Exchange
  • SRPT Nasdaq
  • IIPR Nasdaq
  • Market Cap
  • SRPT 1.7B
  • IIPR 1.5B
  • IPO Year
  • SRPT 1997
  • IIPR 2016
  • Fundamental
  • Price
  • SRPT $21.70
  • IIPR $52.27
  • Analyst Decision
  • SRPT Hold
  • IIPR Hold
  • Analyst Count
  • SRPT 29
  • IIPR 8
  • Target Price
  • SRPT $46.15
  • IIPR $88.75
  • AVG Volume (30 Days)
  • SRPT 22.8M
  • IIPR 368.4K
  • Earning Date
  • SRPT 08-06-2025
  • IIPR 08-06-2025
  • Dividend Yield
  • SRPT N/A
  • IIPR 14.29%
  • EPS Growth
  • SRPT N/A
  • IIPR N/A
  • EPS
  • SRPT N/A
  • IIPR 4.63
  • Revenue
  • SRPT $2,481,531,000.00
  • IIPR $287,883,000.00
  • Revenue This Year
  • SRPT $3.52
  • IIPR N/A
  • Revenue Next Year
  • SRPT N/A
  • IIPR $0.94
  • P/E Ratio
  • SRPT N/A
  • IIPR $11.48
  • Revenue Growth
  • SRPT 64.89
  • IIPR N/A
  • 52 Week Low
  • SRPT $10.42
  • IIPR $45.44
  • 52 Week High
  • SRPT $144.22
  • IIPR $138.35
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 57.32
  • IIPR 52.07
  • Support Level
  • SRPT $17.28
  • IIPR $45.50
  • Resistance Level
  • SRPT $20.61
  • IIPR $54.94
  • Average True Range (ATR)
  • SRPT 1.51
  • IIPR 1.75
  • MACD
  • SRPT 0.96
  • IIPR 0.44
  • Stochastic Oscillator
  • SRPT 95.91
  • IIPR 82.63

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About IIPR Innovative Industrial Properties Inc.

Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.

Share on Social Networks: